A golden cross is when a stock's 50-day moving average rises up through its 200-day — read as a shift to an uptrend. A death cross is the reverse: the 50-day falls down through the 200-day, read as a downtrend.
Each moving average is the average closing price over its window, recalculated daily. When recent prices climb, the faster 50-day pulls above the slower 200-day — the crossing point is the golden cross. When prices roll over, the 50-day sinks back below the 200-day — the death cross. Example (illustrative): a 200-day average flat near $100; after a rally the 50-day climbs from $95 up through $100 (golden cross); if the stock later slides, the 50-day drifts from $105 back down through it (death cross).
By the time a 50-day and 200-day average cross, a large part of the move has usually already happened. The signals whipsaw in sideways markets — firing a golden cross and a death cross within weeks — and because every trader sees the same lines, the plain signal is often already priced in before the cross completes.
Quantustik does not base its forecasts on textbook crossovers — a signal everyone can chart for free is already priced in. Our forecasts come from a quantum-mechanics-based model with calibrated confidence bands. We may show moving averages for context, never as the basis of a recommendation. None of this is investment advice.
It's when a stock's short-term moving average (usually the 50-day) rises up through its long-term average (usually the 200-day), read as a shift into an uptrend — but it is a lagging signal.
The opposite of a golden cross: the 50-day moving average falls down through the 200-day, read as a shift into a downtrend. It confirms a move already underway rather than predicting one.
On their own, not very. They lag because they're built from past prices, they whipsaw in sideways markets, and because every trader watches the same 50/200-day lines, the plain signal is usually already priced in.
Browse all S&P 500 tickers to see this metric applied to individual companies.
Educational research only — not investment advice.